acute ischemic stroke and brain aneurysm Ischemic Stroke, AIS, stroke, Intracranial Aneurysm
Conditions
Interventions
None listed
Sponsors
Ooishi Hidenori
Eligibility
Inclusion criteria
Inclusion criteria: 1) Patients who have undergone endovascular treatment using a neuroguidewire for ischemic stroke or cerebral aneurysm from January 1, 2022 to the date of Ethics Committee approval. 2) Patients who have given consent for the use of their medical information.
Exclusion criteria
Exclusion criteria: 1) Patients who used medical devices not approved in Japan 2) Patients under 18 years of age and those who need to obtain consent from a substitute 3) Patients whom the principal investigator considers to be unjustified as research subjects.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Efficacy: success rate of microcatheter induction Definition of successful induction: a successful induction is considered when any of the following (1) to (4) are met. (1) Was the microcatheter tip able to reach the aneurysm? (2) Was the microcatheter tip or the balloon portion of the balloon catheter able to reach the distal portion beyond the aneurysm? (iii) Was the tip of the microcatheter able to reach just before the site of occlusion or stenosis? (iv) Was the microcatheter tip able to reach the distal portion beyond the site of occlusion or stenosis? | — |
Secondary
| Measure | Time frame |
|---|---|
| Efficacy 1) Reach of the research device (guidewire) to the target site 2) Need for replacement with other neuroguidewire 3) Microcatheter or balloon catheter used in combination (product name) Safety 1) Failure during the procedure related to the research device. 2) Whether or not there are any adverse events that can not be ruled out as causally related to the research device. | — |
Contacts
Public ContactHidenori Ooishi
Juntendo University School of Medicine Juntendo Clinic
Outcome results
None listed